SPA
Sherbrooke Park Advisers’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.5K | Buy |
+11,356
| New | +$57.5K | 0.03% | 493 |
|
|
2025
Q1 | – | Sell |
-26,230
| Closed | -$177K | – | 890 |
|
|
2024
Q4 | $177K | Buy |
+26,230
| New | +$177K | 0.06% | 611 |
|
|
2024
Q3 | – | Sell |
-33,458
| Closed | -$251K | – | 1215 |
|
|
2024
Q2 | $251K | Buy |
+33,458
| New | +$251K | 0.04% | 695 |
|